Back to Search Start Over

Loss of Microbiota Diversity after Autologous Stem Cell Transplant Is Comparable to Injury in Allogeneic Stem Cell Transplant

Loss of Microbiota Diversity after Autologous Stem Cell Transplant Is Comparable to Injury in Allogeneic Stem Cell Transplant

Authors :
Khan, Niloufer
Peled, Jonathan U.
Gomes, Antonio LC
Devlin, Sean M
Rondon-Clavo, Carlos
Clurman, Annelie
Slingerland, John B.
Slingerland, Ann E.
Maloy, Molly
Sung, Anthony D.
Chao, Nelson J.
Sauter, Craig S.
Landau, Heather J.
Ponce, Doris
Gyurkocza, Boglarka
Shah, Gunjan L.
Scordo, Michael
Dahi, Parastoo B.
Perales, Miguel-Angel
Jenq, Robert R.
Giralt, Sergio
Pamer, Eric G.
van den Brink, Marcel R.M.
Source :
Blood; November 2018, Vol. 132 Issue: Supplement 1 p608-608, 1p
Publication Year :
2018

Abstract

Peled: Seres Therapeutics: Research Funding. Sauter:Juno Therapeutics: Consultancy, Research Funding; Sanofi-Genzyme: Consultancy, Research Funding; Spectrum Pharmaceuticals: Consultancy; Novartis: Consultancy; Precision Biosciences: Consultancy; Kite: Consultancy. Shah:Amgen: Research Funding; Janssen: Research Funding. Perales:Novartis: Other: Personal fees; Incyte: Membership on an entity's Board of Directors or advisory committees, Other: Personal fees and Clinical trial support; Merck: Other: Personal fees; Takeda: Other: Personal fees; Abbvie: Other: Personal fees. Jenq:Ziopharm Oncology: Consultancy; Seres Therapeutics, Inc.: Membership on an entity's Board of Directors or advisory committees; MicrobiomeDx: Consultancy; Seres Therapeutics, Inc.: Patents & Royalties.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
132
Issue :
Supplement 1
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs53593032
Full Text :
https://doi.org/10.1182/blood-2018-99-110857